News

Mauna Kea Technologies announces the opening of a safeguard proceeding to restructure its financial liabilities 

31 March 2025

 The aim of the procedure is to optimize the Company’s financial structure in order to adapt it to the needs of its future growth 

The procedure will also provide a protective framework favorable to the progress of ongoing discussions with strategic and financial partners 

The Company’s liabilities prior to the proceedings are frozen during the proceedings 

Paris and Boston, March 31, 2025 – 7:00 p.m. CEST – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that the Tribunal des activités économiques de Paris (Paris Business Court) has granted its request to open safeguard proceedings, in view of its financial situation. The Company’s financial horizon is currently secured until the end of June 2025. 

This initiative is part of a proactive determination by Mauna Kea Technologies’ management to create the most favorable conditions for the success of its transformation, and to maximize the unique value of its technology. During this observation period, the Company will continue to operate under the legal protection offered by the procedure, while benefiting from more favorable conditions to conclude its strategic and financial negotiations. As such, the Company’s liabilities prior to the proceedings are frozen for the duration of the proceedings. 

In this context, Mauna Kea Technologies intends to finalize ongoing discussions with several strategic partners and long-term financial investors. 

At the same time, the Company will engage in negotiations with its creditors to reach a balanced financial structure, reducing its indebtedness and securing the necessary liquidity to enable it to deploy its strategic plan towards profitability. To date, the Company’s liabilities stand at €36 million, including €31 million in financial debt. 

In this context, the Paris Business Court has appointed SELARL THEVENOT PARTNERS, in the person of Aurélia Perdereau, as administrator with monitoring responsibility for Mauna Kea Technologies, and SCP BTSG, in the person of Stéphane Gorrias, as judicial representative. 

The Company will keep the market informed of developments in the proceedings and, more generally, of the financial situation of Mauna Kea Technologies. 

READ THE FULL PRESS RELEASE

Latest News

Mauna Kea Technologies announces entrance into exclusive negotiations for a licensing agreement for Cellvizio® in an important therapeutic area with a major industry player 

Mauna Kea Technologies announces entrance into exclusive negotiations for a licensing agreement for Cellvizio® in an important therapeutic area with a major industry player 

Cellvizio® Now Recommended in New European Society of Gastrointestinal Endoscopy Technical Guideline for Pancreatic Cyst Diagnosis

Cellvizio® Now Recommended in New European Society of Gastrointestinal Endoscopy Technical Guideline for Pancreatic Cyst Diagnosis

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers 

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers